Acer Inc yesterday revised downward its revenue growth to less than 40 percent, citing a weaker-than-expected impact from the release of Microsoft's Vista operating system.
"Our revenues will grow 30 percent to 40 percent compared to last year," company chairman Wang Jeng-tang (王振堂) told shareholders yesterday.
He said that it would take more time before PC sales were stimulated by Vista, which was launched in January, because of software compatibility issues.
International Data Corp (IDC) vice president Bob O'Donnell said last month in Taipei that Vista had failed to live up to the hype that had excited the market, with a lukewarm reception especially from the commercial sector.
"The reality is that people are not buying PCs because of Vista; they buy because they need one," O'Donnell said.
Wang said he remained positive on prospects for the PC industry in the second half, but not as "over optimistic" as he had been earlier. Acer sales for the year would not grow by over 40 percent as he had previously projected, he said.
Acer's consolidated sales were up 16 percent from the previous year at NT$369.09 billion (US$11.15 billion) last year. Net income after tax surpassed the NT$10 billion mark for the first time at NT$10.22 billion.
The meeting yesterday approved the payment of a cash dividend of NT$3.85 and a 1.5 percent stock dividend for last year.
Wang said that Acer will continue to drive to strengthen its presence in Europe, which is its largest market.
Hewlett-Packard Co's first-quarter notebook shipments to Europe reached 1.38 million units, a 53 percent growth year-on-year, and beat Acer's 1.23 million units to become the No. 1 brand in Europe, IDC said.
Wang said Acer is still growing in the region and will not let down its guard with regard to its competitors.
Acer shares rose 1.13 percent to end the day at NT$61.80 on the Taiwan Stock Exchange yesterday.
MOVING ON UP: Taiwan improved in all four areas measured by the IMD, making its biggest leap, from 17th to sixth place, in economic performance Taiwan moved up three spots from last year to place eighth, its best performance since 2013, in the latest annual world competitiveness rankings, released yesterday by the International Institute for Management Development (IMD). Innovation, digitalization, welfare benefits and social cohesion are critical to economic performance, with Switzerland, Sweden, Denmark, the Netherlands and Singapore making up the top five on the list this year, the Switzerland-based institute said, after grading 64 countries and regions based on economic performance, infrastructure, and government and business efficiency. “Leading performers are characterized by varying degrees of investment in innovation, diversified economic activities and supportive public policy,” IMD
With the US opening up to travel, demand in Taiwan for US-bound flights has soared, pushing up ticket prices to most destinations in North America, tourism sources said. Fares for destinations in the US have risen dramatically since the middle of last month, and the trend is expected to continue in the coming months, as California on Tuesday lifted most social distancing and capacity limits put in place to contain the spread of COVID-19, ezTravel Co (易遊網) said in a statement yesterday. The travel agency forecast that the number of tickets sold this month is likely to be double or triple
‘MATTER OF SURVIVAL’: Vice Premier Liu He is to lead the development of ‘third-generation’ chips, a field not yet dominated by any nation or company Chinese President Xi Jinping (習近平) is renewing his years-long push to achieve technology self-sufficiency by tapping a top deputy to shepherd a key initiative aimed at helping domestic chipmakers overcome US sanctions. Chinese Vice Premier Liu He (劉鶴), Xi’s economic czar whose sprawling portfolio spans trade to finance and technology, has been tapped to spearhead the development of so-called “third-generation” chip development and capabilities, and is leading the formulation of a series of financial and policy supports for the technology, people with knowledge of the matter said. It is a nascent field that relies on newer materials and gear beyond traditional silicon,
OPPORTUNITY: The company aims to sell its product soon, as enterovirus vaccines are not available anywhere but China, where firms are only marketing their vaccines locally Medigen Vaccine Biologics Corp’s (高端疫苗) phase 3 clinical trials for an enterovirus 71 (EV71) vaccine completed the multi-regional, multi-central data “unblinding” yesterday, with the results, including safety, immunogenicity and efficacy, meeting its expectations. The company would compile a final analysis report as soon as possible, and apply for the new drug certificate from domestic and foreign drug authorities in the third quarter, Medigen said in a Taiwan Stock Exchange filing yesterday. Its phase 3 trials were conducted in Taiwan and Vietnam with 3,049 participants ranging from two months old to six years old, Medigen said. The company enrolled its first participant for